Avidity Biosciences Announces Upcoming Presentations at 2023 MDA Clinical & Scientific Conference

SAN DIEGO, March 13, 2023 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the company will be presenting two oral…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks